Montserrat Laguno
Research group
- AIDS and HIV infection Accredited researcher (R3A)
Featured publications
-
Dual therapy with etravirine plus raltegravir for virologically suppressed infected patients: a pilot study
Authors:Reference: Journal Of Antimicrobial Chemotherapy 2014. -
Pharmacokinetic study of dual therapy with raltegravir 400 mg twice daily and 1-infected patients
Authors:Reference: Therapeutic Drug Monitoring 2013. -
Differences between HIV-infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel control studies
Authors:Reference: Hiv Medicine 2013. -
Pharmacokinetic study of saquinavir 500 mg plus ritonavir (1000/100 mg twice a day) in HIV-positive pregnant women
Authors:Reference: Therapeutic Drug Monitoring 2011. -
Effect of an induction period of pegylated interferon-alpha2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study
Authors:Reference: Antiviral Therapy 2011. -
The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study
Authors:Reference: Liver Transplantation 2009. -
Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients
Authors:Reference: Hepatology 2009. -
Influence of repeated cycles of structured therapy interruption on the rate of recovery of CD4+ T cells after highly active antiretroviral therapy resumption
Authors:Reference: Journal Of Antimicrobial Chemotherapy 2009. -
Clinicoimmunological progression and response to treatment of long-term nonprogressor HIV-hepatitis C virus-coinfected patients
Authors:Reference: Aids Research And Human Retroviruses 2007. -
Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area
Authors:Reference: Hiv Medicine 2007.
Featured Projects
-
Disfunción endotelial y marcadores de inflamación vascular en los pacientes infectados por el VIH en tratamiento antirretroviral
Principal investigator: Jose Mallolas MasferrerFunder: Universitat de Barcelona (Sede o evento); Ministerio de Sanidad y Consumo ; Universitat de Barcelona (Participante)Duration: 28/12/2004 - 27/12/2007 -
Evaluación de la seguridad y la eficacia de estrategias de tratamiento antirretroviral a demanda en personas infectadas por el virus de la inmunodeficiencia humana.
Principal investigator: Esteban Jose Martinez ChamorroFunder: Universitat de Barcelona (Sede o evento); Ministerio de Sanidad y Consumo ; Universitat de Barcelona (Participante)Duration: 06/11/2002 - 05/11/2005 -
Avaluació de la seguretat i l'eficàcia d'estratègies de tractament antiretroviral a demanda en persones infectades pel virus de la immunodeficiència humana.
Principal investigator: Esteban Jose Martinez ChamorroFunder: Universitat de Barcelona (Sede o evento); Agència d'Avaluació de Tecnologia i Recerca Mèdiques (AATRM) ; Universitat de Barcelona (Participante)Duration: 05/06/2002 - 04/06/2005 -
Factores pronósticos en las miopatías inflamatorias idiopáticas. Estudio clínico, morfológico e inmunogenético
Principal investigator: Josep Maria Grau JunyentFunder: Universitat de Barcelona (Sede o evento); Ministerio de Sanidad y Consumo ; sense especificar (Participante)Code: 99/0231Duration: 01/01/1999 - 31/12/2001 -
Regulación estrogénica de las respuestas biológicas de la célula endotelial relacionadas con la angiogénesis y los mecanismos de reparación vascular
Principal investigator: Maria Cinta Cid XuclàFunder: Fundació Clínic per a la Recerca Biomèdica (Sede o evento); Ministerio de Sanidad y Consumo ; Servicio de Medicina Interna. Hospital Clínic de Barcelona (Participante)Code: 96/2145Duration: 01/01/1997 - 01/01/2000